Adicet Bio (ACET) Competitors $0.72 +0.01 (+1.00%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$0.72 +0.00 (+0.10%) As of 09/5/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACET vs. ADMA, URI, FAST, GWW, WSO, WCC, AIT, AL, GATX, and MSMShould you be buying Adicet Bio stock or one of its competitors? The main competitors of Adicet Bio include ADMA Biologics (ADMA), United Rentals (URI), Fastenal (FAST), W.W. Grainger (GWW), Watsco (WSO), WESCO International (WCC), Applied Industrial Technologies (AIT), Air Lease (AL), GATX (GATX), and MSC Industrial Direct (MSM). Adicet Bio vs. Its Competitors ADMA Biologics United Rentals Fastenal W.W. Grainger Watsco WESCO International Applied Industrial Technologies Air Lease GATX MSC Industrial Direct Adicet Bio (NASDAQ:ACET) and ADMA Biologics (NASDAQ:ADMA) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Which has more risk and volatility, ACET or ADMA? Adicet Bio has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500. Comparatively, ADMA Biologics has a beta of 0.54, indicating that its stock price is 46% less volatile than the S&P 500. Do institutionals & insiders have more ownership in ACET or ADMA? 83.9% of Adicet Bio shares are owned by institutional investors. Comparatively, 75.7% of ADMA Biologics shares are owned by institutional investors. 7.8% of Adicet Bio shares are owned by company insiders. Comparatively, 3.5% of ADMA Biologics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is ACET or ADMA more profitable? ADMA Biologics has a net margin of 44.06% compared to Adicet Bio's net margin of 0.00%. ADMA Biologics' return on equity of 41.01% beat Adicet Bio's return on equity.Company Net Margins Return on Equity Return on Assets Adicet BioN/A -68.48% -57.84% ADMA Biologics 44.06%41.01%28.47% Do analysts prefer ACET or ADMA? Adicet Bio presently has a consensus target price of $6.00, indicating a potential upside of 732.99%. ADMA Biologics has a consensus target price of $27.67, indicating a potential upside of 64.00%. Given Adicet Bio's higher possible upside, equities analysts plainly believe Adicet Bio is more favorable than ADMA Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adicet Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00ADMA Biologics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has higher valuation & earnings, ACET or ADMA? ADMA Biologics has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than ADMA Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdicet Bio$24.99M2.40-$117.12M-$1.31-0.55ADMA Biologics$426.45M9.44$197.67M$0.8619.62 Does the media prefer ACET or ADMA? In the previous week, ADMA Biologics had 4 more articles in the media than Adicet Bio. MarketBeat recorded 7 mentions for ADMA Biologics and 3 mentions for Adicet Bio. ADMA Biologics' average media sentiment score of 1.73 beat Adicet Bio's score of 0.20 indicating that ADMA Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adicet Bio 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ADMA Biologics 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryADMA Biologics beats Adicet Bio on 11 of the 16 factors compared between the two stocks. Get Adicet Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACET vs. The Competition Export to ExcelMetricAdicet BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$59.97M$3.17B$5.81B$9.91BDividend YieldN/A2.26%6.70%4.52%P/E Ratio-0.5521.2476.2926.13Price / Sales2.40426.27529.70172.90Price / CashN/A45.7236.9959.28Price / Book0.329.8711.486.09Net Income-$117.12M-$53.42M$3.29B$266.51M7 Day Performance0.04%2.93%1.28%0.45%1 Month Performance4.83%11.43%8.56%5.05%1 Year Performance-51.33%16.14%61.19%26.03% Adicet Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACETAdicet Bio2.1086 of 5 stars$0.72+1.0%$6.00+733.0%-51.3%$59.97M$24.99M-0.5590ADMAADMA Biologics3.6366 of 5 stars$17.26-0.7%$27.67+60.3%+3.8%$4.12B$426.45M20.07530Positive NewsURIUnited Rentals4.1506 of 5 stars$957.78+0.3%$842.86-12.0%+43.3%$61.53B$15.35B24.7727,900Positive NewsFASTFastenal4.2433 of 5 stars$49.66-1.0%$46.36-6.6%+45.7%$56.99B$7.55B47.7523,702News CoveragePositive NewsAnalyst ForecastGap DownGWWW.W. Grainger4.5412 of 5 stars$1,014.020.0%$1,080.38+6.5%+4.8%$48.48B$17.17B25.7326,000News CoveragePositive NewsAnalyst ForecastWSOWatsco4.165 of 5 stars$402.04+0.1%$484.17+20.4%-9.0%$16.32B$7.62B30.837,295Trending NewsAnalyst RevisionWCCWESCO International4.0077 of 5 stars$220.09-2.4%$223.78+1.7%+46.5%$10.70B$21.82B17.2320,000News CoverageAnalyst ForecastInsider TradeAITApplied Industrial Technologies4.5934 of 5 stars$263.43-1.1%$285.00+8.2%+36.9%$9.95B$4.56B26.036,800Trending NewsAnalyst RevisionALAir Lease4.6144 of 5 stars$60.13-0.9%$59.50-1.1%+50.0%$6.73B$2.73B7.30150News CoverageAnalyst DowngradeGATXGATX2.3956 of 5 stars$168.42-1.0%$177.67+5.5%+26.5%$5.99B$1.59B19.272,150Positive NewsInsider TradeMSMMSC Industrial Direct3.7429 of 5 stars$90.13-0.9%$90.33+0.2%+18.0%$5.02B$3.82B25.467,423News CoveragePositive News Related Companies and Tools Related Companies ADMA Alternatives URI Alternatives FAST Alternatives GWW Alternatives WSO Alternatives WCC Alternatives AIT Alternatives AL Alternatives GATX Alternatives MSM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACET) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adicet Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adicet Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
